This activity has expired. Thank you for using WebBasedCME.com. Continue to check our activities page for additional online CME offerings .


EVALUATION FORM - Managing FPG and PPG With Incretin-Based Therapies: A Therapeutic Double Play


The American Association of Clinical Endocrinologists respects and appreciates your opinions. To assist us in evaluating the effectiveness of this activity and to make recommendations for future educational offerings, please take a few minutes to complete this evaluation form.

0. Have you created an account on WebBasedCME.com? You must register and be signed in to participate and receive CME credit for this activity.



1. Please answer the following questions by selecting the appropriate rating:

5=Outstanding  4=Good  3=Satisfactory  2=Fair  1=Poor

Extent to Which Activity Met the Identified Objectives

Upon completion of this activity, participants should be able to:
 
(A): Compare and contrast the effects of FPG and PPG on overall glycemic control and diabetic complications

1     2     3     4     5    
 
(B): Explain the concept of the incretin effect, and describe defects in incretin secretion and incretin action that occur in type 2 diabetes

1     2     3     4     5    
 
(C): Describe the multiple metabolic defects that occur in type 2 diabetes

1     2     3     4     5    
 
(D): Summarize the effects of GLP-1 and GLP-1 receptor agonists on metabolism

1     2     3     4     5    
 
(E): Discuss the clinical efficacy and safety of incretin-based therapies for the treatment of type 2 diabetes, including contributions to FPG and PPG

1     2     3     4     5    
 
(F): Describe how both the pathophysiologic processes in type 2 diabetes and indicators of glycemic control (A1C, FPG, and PPG) can be used to design a more effective treatment plan for patients with the disease

1     2     3     4     5    

2. Overall Effectiveness of the Activity
 
(A): Course was fair, balanced, and free of commercial bias

1     2     3     4     5    
 
(B): Program objectives were satisfied

1     2     3     4     5    
 
(C): Program content was well organized

1     2     3     4     5    
 
(D): Topic was of interest or related to my educational needs

1     2     3     4     5    
 
(E): Educational content is useful in improving patient care

1     2     3     4     5    
 
(F): Webcast is an appropriate medium for learning

1     2     3     4     5    
 
(G): Overall, activity was effective

1     2     3     4     5    

3. Will the information presented cause you to make any changes in your practice?
Yes
No

4. If Yes, please describe any change(s) you plan to make in your practice as a result of this activity.
 

5. How committed are you to making these changes?
 
(A):   5 - (Very committed)    1 - (Not at all committed)

1     2     3     4     5    

6. Additional comments about this activity?
 

7. Do you feel future activities on this subject matter are necessary and/or important to your practice?
Yes
No

8. Please list any other topics that would be of interest to you for future educational activities:
 

9. Degree:
MD
DO
PharmD
BS
RN
PA
  Other

10. I claim _________ AMA PRA Category 1 Credit(s)™ for participating as a learner in this CME activity (1 credit for each hour of participation, not to exceed 1.5 credits)
 
 hours     minutes  (Not to exceed 1 hr(s) 30 mins)

Return to Activity